Mechanisms involved in the induced differentiation of leukemia cells

Pharmacology and Therapeutics

Volumn 100, Issue 3, 2003, Pages 257-290

  Tsiftsoglou, Asterios S ^a   Pappas, Ioannis S ^a,b   Vizirianakis, Ioannis S ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY OF THESSALY   (Greece)

Author keywords

Apoptosis; Chemical inducers; Differentiation; Hematopoietic cells; Leukemia; Mechanisms

Indexed keywords

2 PYRIDONE DERIVATIVE; 20 EPI 22 ETHOXY 24A,26A,27A TRIHOMO 9,10 SECOCHOLESTA 5,7,10(19) TRIEN 23 YNE 1ALPHA,3BETA,25 TRIOL; 5 AZA 2' DEOXYCYTIDINE; 9,10 SECOCHOLESTA 5,7,10(19),16 TETRAEN 23 YNE 1,3,25 TRIOL; ACTIVIN A; AMIDE; ANTINEOPLASTIC AGENT; AZACITIDINE; BENZODIAZEPINE; CAMPTOTHECIN; COLECALCIFEROL DERIVATIVE; CYTOKINE; DACTINOMYCIN; DIMETHYL SULFOXIDE; DNA TOPOISOMERASE INHIBITOR; FLUCYTOSINE DEOXYRIBOSIDE; FLUOROURACIL; HEMIN; HEXAMETHYLENEBISACETAMIDE; HISTONE DEACETYLASE INHIBITOR; IMATINIB; INOSINATE DEHYDROGENASE INHIBITOR; LACTAM DERIVATIVE; N (2 AMINOPHENYL) 4 (3 PYRIDINYLMETHOXYCARBONYLAMINOMETHYL)BENZAMIDE; PURINE DERIVATIVE; PYRIDINE DERIVATIVE; PYRIMIDINE DERIVATIVE; RETINOID; RO 24 5531; SEOCALCITOL; THIOUREA DERIVATIVE; TRICHOSTATIN A; TUNICAMYCIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; UREA DERIVATIVE; URIDINE DIPHOSPHATE; ZEBULARINE;

ACETYLATION; APOPTOSIS; CANCER CHEMOTHERAPY; CELL CULTURE; CELL CYCLE; CELL DIFFERENTIATION; CELL GROWTH; CELL MATURATION; CELL MEMBRANE; CELL PROLIFERATION; CELL SURVIVAL; CHROMATIN; CHROMATIN CONDENSATION; DNA METHYLATION; DNA REPLICATION; DRUG EFFECT; DRUG POTENCY; ERYTHROLEUKEMIA CELL; FRIEND LEUKEMIA; GENE ACTIVATION; GENE EXPRESSION; GENE REPRESSION; GENETIC TRANSFECTION; HEMATOPOIESIS; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; HUMAN; LEUKEMIA CELL; MESENCHYME CELL; MITOSIS INHIBITION; MOLECULAR CLONING; NONHUMAN; NORTHERN BLOTTING; ONCOGENE C MYC; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTO ONCOGENE; RECEPTOR BINDING; REVIEW; RNA METHYLATION; SIGNAL TRANSDUCTION; STEM CELL;

EID: 0344255770     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2003.09.002     Document Type: Review

References (397)

1. 3. Proc Natl Acad Sci USA. 78:1981;4990-4994.
2. 3 with an oxygen atom in the side chain skeleton. A trial of the development of vitamin D compounds which exhibit potent differentiation-inducing activity without inducing hypercalcemia. FEBS Lett. 226:1987;58-62.
3. 3, is a potent modulator of in vivo immunoregulating activity without inducing hypercalcemia in mice. Endocrinology. 124:1989;2645-2647.
4. Amann J.M., Nip J., Strom D.K., Lutterbach B., Harada H., Lenny N., Downing J.R., Meyers S., Hiebert S.W. ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain. Mol Cell Biol. 21:2001;6470-6483.
5. Amati B., Frank S.R., Donjerkovic D., Taubert S. Function of the c-Myc oncoprotein in chromatin remodeling and transcription. Biochim Biophys Acta. 1471:2001;M135-M145.
6. Amin H.M., Saeed S., Alkan S. Histone deacetylase inhibitors induce caspase-dependent apoptosis and downregulation of daxx in acute promyelocytic leukaemia with t(15;17). Br J Haematol. 115:2001;287-297.
7. Aoyama M., Grabowski D.R., Isaacs R.J., Krivacic K.A., Rybicki L.A., Bukowski R.M., Ganapathi M.K., Hickson I.D., Ganapathi R. Altered expression and activity of topoisomerases during all-trans retinoic acid-induced differentiation of HL-60 cells. Blood. 92:1998;2863-2870.
8. Arcangeli A., Carla M., Del Bene R., Becchetti A., Wanke E., Olivotto M. Polar/apolar compounds induce leukemia cell differentiation by modulating cell-surface potential. Proc Natl Acad Sci USA. 90:1993;5858-5862.
9. Archer S.Y., Meng S., Shei A., Hodin R.A. p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells. Proc Natl Acad Sci USA. 95:1998;6791-6796.
10. Aries A., Trentesaux C., Ottolenghi S., Jardillier J.C., Jeannesson P., Doubeikovski A. Activation of erythroid-specific promoters during anthracycline-induced differentiation of K562 cells. Blood. 87:1996;2885-2890.
11. Ashkenazi A., Dixit V.M. Death receptors: signaling and modulation. Science. 281:1998;1305-1308.
12. Attwood J.T., Yung R.L., Richardson B.C. DNA methylation and the regulation of gene transcription. Cell Mol Life Sci. 59:2002;241-257.
13. Baker A.R., McDonnell D.P., Hughes M., Crisp T.M., Mangelsdorf D.J., Haussler M.R., Pike J.W., Shine J., O'Malley B.W. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci USA. 85:1988;3294-3298.
14. Balzarini J., Stet L., Matsuda A., Wiebe L., Knauss E., De Clercq E. Metabolism of EICAR (5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide), a potent inhibitor of inosinate dehydrogenase. Adv Exp Med Biol. 431:1998;723-728.
15. Belasco J., Brawerman G. Control of messenger RNA stability. 1993;Academic Press, San Diego.
16. Benedetti L., Levin A.A., Scicchitano B.M., Grignani F., Allenby G., Diverio D., Lo Coco F., Avvisati G., Ruthardt M., Adamo S., Pelicci P.G., Nervi C. Characterization of the retinoid binding properties of the major fusion products present in acute promyelocytic leukemia cells. Blood. 90:1997;1175-1185.
17. Bianchi N., Osti F., Rutigliano C., Corradini F.G., Borsetti E., Tomassetti M., Mischiati C., Feriotto G., Gambari R. The DNA-binding drugs mithramycin and chromomycin are powerful inducers of erythroid differentiation of human K562 cells. Br J Haematol. 104:1999;258-265.
18. Bianchi N., Ongaro F., Chiarabelli C., Gualandi L., Mischiati C., Bergamini P., Gambari R. Induction of erythroid differentiation of human K562 cells by cisplatin analogs. Biochem Pharmacol. 60:2000;31-40.
19. Bianchi N., Chiarabelli C., Borgatti M., Mischiati C., Fibach E., Gambari R. Accumulation of gamma-globin mRNA and induction of erythroid differentiation after treatment of human leukaemic K562 cells with tallimustine. Br J Haematol. 113:2001;951-961.
20. Bianchi Scarrà G.L., Romani M., Coviello D.A., Garre C., Ravazzolo R., Vidali G., Ajmar F. Terminal erythroid differentiation in the K-562 cell line by 1-beta-D-arabinofuranosylcytosine: accompaniment by c-myc messenger RNA decrease. Cancer Res. 46:1986;6327-6332.
21. Biedler J.L. Drug resistance: genotype versus phenotype. Cancer Res. 54:1994;666-678.
22. Bodner A.J., Ting R.C., Gallo R.C. Induction of differentiation of human promyelocytic leukemia cells (HL-60) by nucleosides and methotrexate. J Natl Cancer Invest. 67:1981;1025-1030.
23. Bonnet D., Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 3:1997;730-737.
24. Boon K., Caron H.N., van Asperen R., Valentijn L., Hermus M.C., van Sluis P., Roobeek I., Weis I., Voute P.A., Schwab M., Versteeg R. N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis. EMBO J. 20:2001;1383-1393.
25. Breems-de Ridder M.C., Lowenberg B., Jansen J.H. Retinoic acid receptor fusion proteins: friend or foe. Mol Cell Endocrinol. 165:2000;1-6.
26. Breitman T.R., Selonick S.E., Collins S.J. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA. 77:1980;2936-2940.
27. Breslow R., Jursic B., Yan Z.F., Friedman E., Leng L., Ngo L., Rifkind R.A., Marks P.A. Potent cytodifferentiating agents related to hexamethylenebisacetamide. Proc Natl Acad Sci USA. 88:1991;5542-5546.
28. Brown D.T., Wellman S.E., Sittman D.B. Changes in the levels of three different classes of histone mRNA during murine erythroleukemia cell differentiation. Mol Cell Biol. 5:1985;2879-2886.
29. Brown D.T., Yang Y.-S., Sittman D.B. Histone gene switching in murine erythroleukemia cells is differentiation specific and occurs without loss of cell cycle regulation. Mol Cell Biol. 8:1988;4406-4415.
30. Burd C.G., Dreyfuss G. Conserved structures and diversity of functions of RNA-binding proteins. Science. 265:1994;615-621.
31. Busfield S.J., Klinken S.P. Erythropoietin-induced stimulation of differentiation and proliferation in J2E cells is not mimicked by chemical induction. Blood. 80:1992;412-419.
32. Camper S.A., Albers R.J., Coward J.K., Rottman F.M. Effect of undermethylation on mRNA cytoplasmic appearance and half-life. Mol Cell Biol. 4:1984;538-543.
33. Canellos G. Chronic leukemia. DeVita V.T. Jr., Hellman S.A., Rosenberg J.B. Cancer Principles and Practice of Oncology. 1982;1427-1438 Lippincott, Philadelphia.
34. Cantoni G.L. The centrality of S-adenosylhomocysteinase in the regulation of the biological utilization of S-adenosylmethionine. Borchardt R.T., Creveling C.R., Ueland P.M. Biological Methylation and Drug Design. 1986;227-238 Humana Press, Clifton, NJ.
35. Cantor A.B., Orkin S.H. Hematopoietic development: a balancing act. Curr Opin Genet Dev. 11:2001;513-519.
36. Cantor A.B., Orkin S.H. Transcriptional regulation of erythropoiesis: an affair involving multiple partners. Oncogene. 21:2002;3368-3376.
37. Capdeville R., Buchdunger E., Zimmermann J., Matter A. Glivec (STI-571, imatinib), a rationally developed, targeted anticancer drug. Nat Rev Drug Discov. 1:2002;493-502.
38. Castaigne S., Chomienne C., Daniel M.T., Ballerini P., Berger R., Fenaux P., Degos L. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia: I. Clinical results. Blood. 76:1990;1704-1709.
39. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J. 10:1996;940-954.
40. Champlin R., Gale R.P. Acute myelogenous leukemia: recent advances in therapy. Blood. 69:1987;1551-1562.
41. Charney P., Maniatis T. Transcriptional regulation of globin gene expression in the human erythroid cell line K562. Science. 220:1983;1281-1283.
42. Chen J., Kremer C.S., Bender T.P. A Myb dependent pathway maintains Friend murine erythroleukemia cells in an immature and proliferating state. Oncogene. 21:2002;1859-1869.
43. 1 histone mRNAs in mouse erythroleukemia cells is regulated by c-myc. Mol Cell Biol. 9:1989;2332-2340.
44. Cheng J.C., Matsen C.B., Gonzales F.A., Ye W., Greer S., Marquez V.E., Jones P.A., Selker E.U. Inhibition of DNA methylation and reactivation of silenced genes by zebularine. J Natl Cancer Inst. 95:2003;399-409.
45. Chiang P.K., Miura G.A. S-adenosylhomocysteine hydrolase. Borchardt R.T., Creveling C.R., Ueland P.M. Biological Methylation and Drug Design. 1986;239-251 Humana Press, Clifton, NJ.
46. Christman J.K., Price P., Pedrinan L., Acs G. Correlation between hypomethylation of DNA and expression of globin genes in Friend erythroleukemia cells. Eur J Biochem. 81:1977;53-61.
47. Christman J.K., Mendelsohn N., Herzog D., Schneiderman N. Effect of 5-azacytidine on differentiation and DNA methylation in human promyelocytic leukemia cells (HL-60). Cancer Res. 43:1983;763-769.
48. Christopherson R.I., Lyons S.D. Potent inhibitors of de novo pyrimidine and purine biosynthesis as chemotherapeutic agents. Med Res Rev. 10:1990;505-548.
49. + RNA stability in murine erythroleukemia cells by dexamethasone. Mol Cell Differ. 2:1994;329-349.
50. Cioè L., McNab A., Hubbell H.R., Meo P., Curtis P., Rovera G. Differential expression of the globin genes in human leukemia K562(S) cells induced to differentiate by hemin or butyric acid. Cancer Res. 41:1981;237-243.
51. Clark S.S., McLaughlin J., Timmons M., Pendergast A.M., Ben-Neriah Y., Dow L.W., Crist W., Rovera G., Smith S.D., Witte O.N. Expression of a distinctive BCR-ABL oncogene in Ph1-positive acute lymphocytic leukemia (ALL). Science. 239:1988;775-777.
52. Clarke M.F., Kukowska-Latallo J.F., Westin E., Smith M., Prochownik E.V. Constitutive expression of a c-myb cDNA blocks Friend murine erythroleukemia cell differentiation. Mol Cell Biol. 8:1988;884-892.
53. Cohen A., Petsche D., Grunberger T., Freedman M.H. Interleukin 6 induces myeloid differentiation of a human biphenotypic leukemic cell line. Leuk Res. 16:1992;751-760.
54. Collins S.J., Russeti F.W., Gallanger R.E., Gallo R.C. Terminal differentiation of human promyelocytic leukemia cells induced by dimethylsulfoxide (DMSO) and other polar solvents. Proc Natl Acad Sci USA. 75:1978;2458-2462.
55. Collins S.J., Bodner A., Ting R., Gallo R.C. Induction of morphological and functional differentiation of human promyelocytic leukemia cells (HL-60) by compounds which induce differentiation of murine leukemia cells. Int J Cancer. 25:1980;213-218.
56. Collins S.J., Robertson K.A., Mueller L. Retinoic acid-induced granulocytic differentiation of HL-60 myeloid leukemia cells is mediated directly through the retinoic acid receptor (RAR-alpha). Mol Cell Biol. 10:1990;2154-2163.
57. Constantinou A., Henning-Chubb C., Huberman E. Novobiocin- and phorbol-12-myristate-13-acetate-induced differentiation of human leukemia cells associated with a reduction in topoisomerase II activity. Cancer Res. 49:1989;1110-1117.
58. Coppola J.A., Parker J.M., Schuler G.D., Cole M.D. Continued withdrawal from the cell cycle and regulation of cellular genes in mouse erythroleukemia cells blocked in differentiation by the c-myc oncogene. Mol Cell Biol. 9:1989;1714-1720.
59. Coppola J.A., Lewis B.A., Cole M.D. Increased retinoblastoma gene expression is associated with late stages of differentiation in many different cell types. Oncogene. 5:1990;1731-1733.
60. Corin R.E., Haspel H.C., Peretz A.M., Sonenberg M., Rifkind R.A. Antagonistic effect of butyrate on hexamethylene bisacetamide induced differentiation of murine erythroleukemia cells. Cancer Res. 46:1986;1136-1141.
61. Creusot F., Acs G., Christman J.K. Inhibition of DNA methyltransferase and induction of Friend erythroleukemia cell differentiation by 5-azacytidine and 5-aza-2′-deoxycytidine. J Biol Chem. 257:1982;2041-2048.
62. Cui Y., Golob J., Kelleher E., Ye Z., Pardoll D., Cheng L. Targeting transgene expression to antigen-presenting cells derived from lentivirus-transduced engrafting human hematopoietic stem/progenitor cells. Blood. 99:2002;399-408.
63. minor globin nuclear transcripts of Friend erythroleukemia cells induced to differentiate in culture. J Biol Chem. 255:1980;8971-8974.
64. Danenberg P.V., Heidelberger C., Mulkins M.A., Peterson A.R. The incorporation of 5-fluoro-2′-deoxyuridine into DNA of mammalian tumor cells. Biochem Biophys Res Commun. 102:1981;654-658.
65. Dean A., Evard F., Schneider A.B., Schechter A.N. Induction of hemoglobin accumulation by hemin is reversible. Science. 220:1983;1281-1283.
66. Degos L., Wang Z.Y. All trans retinoic acid in acute promyelocytic leukemia. Oncogene. 20:2001;7140-7145.
67. Depraetere S., Vanhaesebroeck B., Fiers W., Willems J., Joniau M. Polar agents with differentiation inducing capacity potentiate tumor necrosis factor-mediated cytotoxicity in human myeloid lines. J Leukoc Biol. 57:1995;141-151.
68. Dexter T.M. Biology of haematopoietic cell growth factors. Tsiftsoglou A.S., Sartorelli A.C., Housman D.E., Dexter T.M. Tumor Biology: Regulation of Cell Growth, Differentiation and Genetics in Cancer. NATO ASI Series. vol. H99:1996;39-57 Springer-Verlag, Berlin.
69. Diaz C., Lee A.T., McConkey D.J., Schroit A.J. Phosphatidylserine externalization during differentiation-triggered apoptosis of erythroleukemia cells. Cell Death Differ. 6:1999;218-226.
70. Dijkwel P.A., Wanka F. Enhanced release of nascent single strands from DNA synthesized in the presence of arabinosylcytosine. Biochim Biophys Acta. 520:1978;461-471.
71. Dimitrovsky E., Keuhl W.M., Hollins G.F., Kirsch I.R., Bender T.P., Segal S. Expression of a transfected human c-myc oncogene inhibits differentiation of a mouse erythroleukemia cell line. Nature. 322:1986;748-750.
72. Dretaki, P. I., Kritis, A. A., Pappas, I. S., & Tsiftsoglou, A. S. (1999). Cell death targeted drugs: II. The inducer of neoplastic cell differentiation (UDP-4) potentiates the killing action of human recombinant tumor necrosis factor alpha (rhTNF-α) in malignant cells. 1999 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics: Discovery, Development, and Clinical Validation, November 16-19, Washington, DC.
73. Dolznig H., Boulmé F., Stangl K., Deiner E.M., Mikulits W., Beug H., Müllner E.W. Establishment of normal, terminally differentiating mouse erythroid progenitors: molecular characterization by cDNA arrays. FASEB J. 15:2001;1442-1444.
74. Domen J. The role of apoptosis in regulating hematopoietic stem cell numbers. Apoptosis. 6:2001;239-252.
75. Domen J., Weissman I.L. Hematopoietic stem cells need two signals to prevent apoptosis; Bcl-2 can provide one of these, kitl/c-kit signaling the other. J Exp Med. 192:2000;1707-1718.
76. 3 analogs on growth and differentiation of human myeloid leukemic cells. Cancer Chemother Pharmacol. 41:1998;275-280.
77. Dunn B.K., Cogliati T., Cultraro C.M., Bar-Ner M., Segal S. Regulation of murine Max (Myn) parallels the regulations of c-myc in differentiating murine erythroleukemia cells. Cell Growth Differ. 5:1994;847-854.
78. Ellis A.L., Zwelling L.A. Time course of phorbol-12-myristate-13-acetate (PMA)-induced down-regulation of topoisomerase II in human leukemia cells. Biochem Pharmacol. 48:1994;1842-1845.
79. Enver T., Greaves M. Loops, lineage, and leukemia. Cell. 94:1998;9-12.
80. Enver T., Heyworth C.M., Dexter T.M. Do stem cells play dice? Blood. 92:1998;348-351.
81. Erard F., Dean A., Schechter A.N. Inhibitors of cell division reversibly modify hemoglobin concentration in human erythroleukemia K562 cells. Blood. 58:1981;1236-1239.
82. - cell transduction via lentivirus-based gene transfer vectors. Hum Gene Ther. 10:1999;1479-1489.
83. Fialkow P.J. Clonal evolution of human myeloid leukemias. Bishop J.M., Rowley J.D., Greaves M. Genes and Cancer. 1984;215-226 Alan R. Liss, New York.
84. Fialkow P.J., Singer J.W., Adamson J.W., Vaidya K., Dow L.W., Ochs J., Moohr J.W. Acute nonlymphocytic leukemia: heterogeneity of stem cell origin. Blood. 57:1981;1068-1073.
85. Fibach E., Burke L.P., Schechter A.N., Noguchi C.T., Rodgers G.P. Hydroxyurea increases fetal hemoglobin in cultured erythroid cells derived from normal individuals and patients with sickle cell anemia or beta-thalassemia. Blood. 81:1993;1630-1635.
86. DiFiore P.P., Grieco M., Pinto A., Attadia V., Porcelli M., Cacciapuoti G., Carteni-Farina M. Inhibition of dimethylsulfoxide-induced differentiation of Friend erythroleukemic cells by 5′-methylthioadenosine. Cancer Res. 44:1984;4096-4103.
87. Fisher A.G. Cellular identity and lineage choice. Nat Rev Immunol. 2:2002;1-6.
88. Fontana J.A., Emler C., Ku K., McClung J.K., Butcher F.R., Durham J.P. Cyclic AMP-dependent and -independent protein kinases and protein phosphorylation in human promyelocytic leukemia (HL60) cells induced to differentiate by retinoic acid. J Cell Physiol. 120:1984;49-60.
89. Fordis C.M., Anagnou N.P., Dean A., Nienhuis A.W., Schechter A.N. A beta-globin gene, inactive in the K562 leukemic cell, functions normally in a heterologous expression system. Proc Natl Acad Sci USA. 81:1984;4485-4489.
90. Francastel C., Mazouzi Z., Robert-Lézénès J. Co-induction of c-fos and junB during the latent period preceding commitment of Friend erythroleukemia cells to differentiation. Leukemia. 6:1992;935-939.
91. Francastel C., Groisman R., Pfarr C.M., Robert- Lézénès J. Antisense c-jun overcomes a differentiation block in a murine erythroleukemia cell line. Oncogene. 9:1994;1957-1964.
92. Friend C., Scher W., Holland J.G., Sato T. Hemoglobin synthesis in murine virus-induced leukemic cells in vitro: stimulation of erythroid differentiation by dimethylsulfoxide. Proc Natl Acad Sci USA. 68:1971;378-382.
93. Friedman E.A., Schildkraut C.L. Terminal differentiation in cultured Friend erythroleukemia cells. Cell. 12:1977;901-913.
94. 3 with side-chain modifications. Bioorg Med Chem. 9:2001;525-535.
95. Fujita H., Yamamoto M., Yamagami T., Hayashi N., Sassa S. Erythroleukemia differentiation: distinctive responses of the erythroid-specific and the nonspecific delta-aminolevulinate synthase mRNA. J Biol Chem. 266:1991;17494-17502.
96. Gambari R., del Senno L., Barbieri R., Viola L., Tripodi M., Raschella G., Fantoni A. Human leukemia K-562 cells: induction of erythroid differentiation by 5-azacytidine. Cell Differ. 14:1984;87-97.
97. Geller R., Levenson R., Housman D. Significance of the cell cycle in commitment of murine erythroleukemia cells to erythroid differentiation. J Cell Physiol. 95:1978;213-222.
98. Gelmetti V., Zhang J., Fanelli M., Minucci S., Pelicci P.G., Lazar M.A. Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO. Mol Cell Biol. 18:1998;7185-7191.
99. Ghysdael J., Quang C.T., Deiner E.M., Dolznig H., Müllner E.W., Beug H. Erythroid cell development and leukemic transformation: interplay between signal transduction, cell cycle control and oncogenes. Pathol Biol. 48:2000;211-226.
100. Gianni' M., Kalac Y., Ponzanelli I., Rambaldi A., Terao M., Garattini E. Tyrosine kinase inhibitor STI571 potentiates the pharmacologic activity of retinoic acid in acute promyelocytic leukemia cells: effects on the degradation of RARalpha and PML-RARalpha. Blood. 97:2001;3234-3243.
101. Gore S.D., Samid D., Weng L.J. Impact of the putative differentiating agents sodium phenylbutyrate and sodium phenylacetate on proliferation, differentiation, and apoptosis of primary neoplastic myeloid cells. Clin Cancer Res. 3:1997;1755-1762.
102. Gougoumas D.D., Vizirianakis I.S., Tsiftsoglou A.S. Transcriptional activation of prion protein gene in growth-arrested and differentiated mouse erythroleukemia and human neoplastic cells. Exp Cell Res. 264:2001;408-417.
103. Goutts M., Brawerman G. A 5′ exoribonuclease from cytoplasmic extracts of mouse sarcoma 180 ascites cells. Biochem Biophys Acta. 1173:1993;57-62.
104. Goutts M., Krowczynska A., Brawerman G. Protection of mRNA against nucleases in cytoplasmic extracts of mouse sarcoma ascites cells. Biochem Biophys Acta. 1173:1993;49-56.
105. Graf T. Differentiation plasticity of hematopoietic cells. Blood. 99:2002;3089-3101.
106. Green A.R., Lints T., Visvader J., Harvey R., Begley C.G. SCL is coexpressed with GATA-1 in hemopoietic cells but is also expressed in developing brain. Oncogene. 7:1992;653-660.
107. Green A.R., Rockman S., DeLuca E., Begley C.G. Induced myeloid differentiation of K562 cells with downregulation of erythroid and megakaryocytic transcription factors: a novel experimental model for hemopoietic lineage restriction. Exp Hematol. 21:1993;525-531.
108. L expression. Blood. 94:1999;87-96.
109. Griffin J., Munroe D., Major P., Kufe D. Induction of differentiation of human myeloid leukemia cells by inhibitors of DNA synthesis. Exp Hematol. 10:1982;774-781.
110. Grignani F., De Matteis S., Nervi C., Tomassoni L., Gelmetti V., Cioce M., Fanelli M., Ruthardt M., Ferrara F.F., Zamir I., Seiser C., Grignani F., Lazar M.A., Minucci S., Pelicci P.G. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Nature. 391:1998;815-818.
111. Gusella J.F., Housman D. Induction of erythroid differentiation in vitro by purines and purine analogues. Cell. 8:1976;263-269.
112. Gusella J., Geller R., Clarke B., Weeks V., Housman D. Commitment to erythroid differentiation by Friend erythroleukemia cells: a stochastic analysis. Cell. 9:1976;221-229.
113. Gusella J.F., Tsiftsoglou A.S., Volloch V., Weil C., Newman J., Housman D.E. Dissociation of hemoglobin accumulation and commitment during murine erythroleukemia cell differentiation by treatment with imidazole. J Cell Physiol. 113:1982;179-185.
114. Haces A., Breitman T.R., Driscoll J.S. Chemical differentiating agents. Differentiation of HL-60 cells by hexamethylenebis[acetamide] analogues. J Med Chem. 30:1987;405-409.
115. L induction during terminal differentiation of friend erythroleukaemia cells correlates with delay of apoptosis and loss of proliferative capacity but not with haemoglobinization. Cell Death Differ. 6:1999;166-174.
116. Hahn W.C., Weinberg R.A. Modelling of molecular circuitry of cancer. Nat Rev Cancer. 2:2002;331-341.
117. Harrison P.R. Analysis of erythropoiesis at the molecular level. Nature. 262:1976;353-356.
118. Hasinoff B.B., Abram M.E., Barnabe N., Khelifa T., Allan W.P., Yalowich J.C. The catalytic DNA topoisomerase II inhibitor dexrazoxane (ICRF-187) induces differentiation and apoptosis in human leukemia K562 cells. Mol Pharmacol. 59:2001;453-461.
119. Hass R., Hirano M., Kharbanda S., Rubin E., Meinhardt G., Kufe D. Resistance to phorbol ester-induced differentiation of a U-937 myeloid leukemia cell variant with a signaling defect upstream to Raf-1 kinase. Cell Growth Differ. 4:1993;657-663.
120. Hatse S., De Clercq E., Balzarini J. Evidence for distinction of the differentiation-inducing activities and cytostatic properties of 9-(2-phosphonylmethoxyethyl)-adenine and a variety of differentiation-inducing agents in human erythroleukemia K562 cells. Mol Pharmacol. 50:1996;1231-1242.
121. Hatse S., De Clercq E., Balzarini J. Role of antimetabolites of purine and pyrimidine nucleotide metabolism in tumor cell differentiation. Biochem Pharmacol. 58:1999;539-555.
122. Hatse S., Schols D., De Clercq E., Balzarini J. 9-(2- Phosphonylmethoxyethyl)adenine induces tumor cell differentiation or cell death by blocking cell cycle progression through the S phase. Cell Growth Differ. 10:1999;435-446.
123. He H., Wang X., Gorospe M., Holbrook N.J., Trush M.A. Phorbol ester-induced mononuclear cell differentiation is blocked by the mitogen-activated protein kinase kinase (MEK) inhibitor PD98059. Cell Growth Differ. 10:1999;307-315.
124. He L.Z., Tolentino T., Grayson P., Zhong S., Warrell R.P. Jr., Rifkind R.A., Marks P.A., Richon V.M., Pandolfi P.P. Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia. J Clin Invest. 108:2001;1321-1330.
125. Heidelberger C., Danenberg P.V., Moran R.G. Fluorinated pyrimidines and their nucleosides. Adv Enzymol Relat Areas Mol Biol. 54:1983;58-119.
126. Hensold J.O., Housman D.E. Decreased expression of the stress protein HSP70 is an early event in murine erythroleukemic cell differentiation. Mol Cell Biol. 8:1988;2219-2223.
127. Hermans A., Heisterkamp N., von Linden M., van Baal S., Meijer D., van der Plas D., Wiedemann L.M., Groffen J., Bootsma D., Grosveld G. Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia. Cell. 51:1987;33-40.
128. Heyworth C., Gale K., Dexter M., May G., Enver T. A GATA-2/estrogen receptor chimera functions as a ligand-dependent negative regulator of self-renewal. Genes Dev. 13:1999;1847-1860.
129. 6-methyladenosylhomosysteine an inhibitor of RNA methyltransferases. J Biol Chem. 253:1978;2905-2907.
130. Hoffman R., Ibrahim N., Murnane M.J., Diamond A., Forget B.G., Levere R.D. Hemin control of heme biosynthesis and catabolism in a human leukemia cell line. Blood. 56:1980;567-570.
131. Hoffman B., Amanullah A., Shafarenko M., Liebermann D.A. The proto-oncogene c-myc in hematopoietic development and leukemogenesis. Oncogene. 21:2002;3414-3421.
132. Hoffman-Liebermann B., Liebermann D.A. Interleukin-6- and leukemia inhibitory factor-induced terminal differentiation of myeloid leukemia cells is blocked at an intermediate stage by constitutive c-myc. Mol Cell Biol. 11:1991;2375-2381.
133. Holland J.F., Frei E., Bast R.C., Kufe D.W., Morton D.L., Weichefbaun R.R. Cancer Medicine. 1993;Lea and Febigen, Philadelphia.
134. Honma Y., Okabe-Kado J., Hozumi M., Uehara Y., Mizuno S. Induction of erythroid differentiation of K562 human leukemic cells by herbimycin A, an inhibitor of tyrosine kinase activity. Cancer Res. 49:1989;331-334.
135. Hotti A., Järvinen K., Siivola P., Höltta E. Caspases and mitochondria in c-Myc-induced apoptosis: identification of ATM as a new target of caspases. Oncogene. 19:2000;2354-2362.
136. Housman D., Levenson R., Volloch V., Tsiftsoglou A., Gusella J.F., Parker D., Kernen J., Mitrani A., Weeks V., Witte O., Besmer P. Control of proliferation and differentiation in cells transformed by Friend virus. Cold Spring Harbor Symp Quant Biol. 44:1980;1177-1185.
137. kip1 and inactivation of cdk2 kinase. Blood. 96:2000;2746-2754.
138. Huberman E., Callaham M.F. Induction of terminal differentiation in human promyelocytic leukemia cells by tumor-promoting agents. Proc Natl Acad Sci USA. 76:1979;1293-1297.
139. Hyman T., Rothmann C., Neller A., Maluc Z., Salzbergm S. Structural characterization of erythroid and megakaryocytic differentiation in Friend erythroleukemia cells. Exp Hematol. 29:2001;563-571.
140. 3 on a human promyelocytic leukemia cell, HL-60, at both the receptor and the postreceptor steps. Arch Biochem Biophys. 293:1992;181-186.
141. Inai K., Tsutani H., Yamauchi T., Fukushima T., Iwasaki H., Imamura S., Wano Y., Nemoto Y., Naiki H., Ueda T. Differentiation induction in non-lymphocytic leukemia cells upon treatment with mycophenolate mofetil. Leuk Res. 24:2000;761-768.
142. Jiang H., Lin J., Su Z.Z., Collart F.R., Huberman E., Fisher P.B. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene. 9:1994;3397-3406.
143. Jones P.A., Baylin S.B. The fundamental role of epigenetic events in cancer. Nat Rev Genet. 3:2002;415-428.
144. Jones P.A., Takai D. The role of DNA methylation in mammalian epigenetics. Science. 293:2001;1068-1070.
145. Juin P., Hueber A.-O., Littlewood T., Evan G. C-Myc-induced sensitization to apoptosis is mediated through cytochrome c release. Genes Dev. 13:1999;1367-1381.
146. Jung M., Brosch G., Kolle D., Scherf H., Gerhauser C., Loidl P. Amide analogues of trichostatin A as inhibitors of histone deacetylase and inducers of terminal cell differentiation. J Med Chem. 42:1999;4669-4679.
147. Kamijo R., Takeda K., Nagumo M., Konno K. Effects of combinations of transforming growth factor-beta 1 and tumor necrosis factor on induction of differentiation of human myelogenous leukemic cell lines. J Immunol. 144:1990;1311-1316.
148. Kastner P., Mark M., Chambon P. Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life? Cell. 83:1995;859-869.
149. Kelly L.M., Englmeier U., Lafon I., Sieweke M.H., Graf T. MafB is an inducer of monocytic differentiation. EMBO J. 19:2000;1987-1997.
150. Kharbanda S.M., Sherman M.L., Spriggs D.R., Kufe D.W. Effects of tiazofurin on protooncogene expression during HL-60 cell differentiation. Cancer Res. 48:1988;5965-5968.
151. Kharbanda S., Saleem A., Emoto Y., Stone R., Rapp U., Kufe D. Activation of Raf-1 and mitogen-activated protein kinases during monocytic differentiation of human myeloid leukemia cells. J Biol Chem. 269:1994;872-878.
152. Khochbin S., Principaud E., Chabanas A., Lawrence J.-J. Early events in murine erythroleukemia cells induced to differentiate. Accumulation and gene expression of the transformation-associated cellular protein p53. J Mol Biol. 200:1988;55-64.
153. Kihara-Negishi F., Yamada T., Kubota Y., Kondoh N., Yamamoto H., Abe M., Shirai T., Hashimoto Y., Oikawa T. Down-regulation of c-myc and bcl-2 gene expression in PU.1-induced apoptosis in murine erythroleukemia cells. Int J Cancer. 76:1998;523-530.
154. Kihara-Negishi F., Yamamoto H., Suzuki M., Yamada T., Sakurai T., Tamura T., Oikawa T. In vivo complex formation of PU.1 with HDAC1 associated with PU.1-mediated transcriptional repression. Oncogene. 20:2001;6039-6047.
155. Kim C.H., Sarma R.H. Spatial configuration of the bizarre 5′ terminus of mammalian mRNA. J Am Chem Soc. 100:1978;1571-1590.
156. Kirsch I.R., Bertness V., Silver J., Hollis G.F. Regulated expression of the c-myb and c-myc oncogenes during erythroid differentiation. J Cell Biochem. 32:1986;11-21.
157. 1. Proc Natl Acad Sci USA. 90:1993;6746-6750.
158. 3 receptor RNA: expression in hematopoietic cells. Blood. 77:1991;1238-1247.
159. Klausner R.D., Rouault T.A., Harford J.B. Regulating the fate of mRNA: the control of cellular iron metabolism. Cell. 72:1993;19-28.
160. Klefstrom J., Vastrik I., Saksela E., Valle J., Eilers M., Alitalo K. c-Myc induces cellular susceptibility to the cytotoxic action of TNF-alpha. EMBO J. 13:1994;5442-5450.
161. Klinken S.P., Billelo J., Bauer S., Morse H.C. III, Thorgeirsson S.S. Altered expression of β-globin, transferrin receptor, and ornithine decarboxylase in Friend murine erythroleukemia cells inhibited by α-difluoromethylornithine. Cancer Res. 47:1987;2638-2644.
162. Komatsu N., Kirito K., Shimizu R., Kunitama M., Yamada M., Uchida M., Takatoku M., Eguchi M., Miura Y. In vitro development of erythroid and megakaryocytic cells from a UT-7 subline, UT-7/GM. Blood. 89:1997;4021-4033.
163. Koury M.J., Sawyer S.T., Brandt S.J. New insights into erythropoiesis. Curr Opin Hematol. 9:2002;93-100.
164. Kramer O.H., Gottlicher M., Heinzel T. Histone deacetylase as a therapeutic target. Trends Endocrinol Metab. 12:2001;294-300.
165. Kume T., Tsuneizumi K., Watanabe T., Thomas M.L., Oishi M. Induction of specific protein tyrosine phosphatase transcripts during differentiation of mouse erythroleukemia cells. J Biol Chem. 269:1994;4709-4712.
166. Kurz E.U., Wilson S.E., Leader K.B., Sampey B.P., Allan W.P., Yalowich J.C., Kroll D.J. The histone deacetylase inhibitor sodium butyrate induces DNA topoisomerase II alpha expression and confers hypersensitivity to etoposide in human leukemic cell lines. Mol Cancer Ther. 1:2001;121-131.
167. Kyriakis J.M., Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev. 81:2001;807-869.
168. Lachman H.M., Skoultchi A.I. Expression of c-myc changes during differentiation of mouse erythroleukemia cells. Nature. 310:1984;592-594.
169. Lachman H.M., Cheng G., Skoultchi A.I. Transfection of mouse erythroleukemia cells with myc sequences changes the rate of induced commitment to differentiate. Proc Natl Acad Sci USA. 83:1986;6480-6484.
170. Laird P.W. The power and the promise of DNA methylation markers. Nat Rev Cancer. 3:2003;253-266.
171. Larsen A.K. Involvement of DNA topoisomerases and DNA topoisomerase inhibitors in the induction of leukemia cell differentiation. Ann Oncol. 5:1994;679-688.
172. Lasorella A., Noseda M., Beyna M., Yokota Y., Iavarone A. Id2 is a retinoblastoma protein target that mediates signalling by myc oncoproteins. Nature. 47:2000;592-598.
173. Laouar A., Glesne D., Huberman E. Protein kinase C-β, fibronectin, α5β1-integrin, and tumor necrosis factor-α are required for phorbol diester-induced apoptosis in human myeloid leukemia cells. Mol Carcinog. 32:2001;195-205.
174. 3 receptors in human promyelocytic leukemic cells (HL-60) during homologous regulation. J Biol Chem. 264:1989;13701-13705.
175. Leszczyniecka M., Roberts T., Dent P., Grant S., Fisher P.B. Differentiation therapy of human cancer: basic science and clinical applications. Pharmacol Ther. 90:2001;105-156.
176. Leung K.N., Mak N.K., Fung M.C., Hapel A.J. Synergistic effect of IL-4 and TNF-alpha in the induction of monocytic differentiation of a mouse myeloid leukaemic cell line (WEHI-3B JCS). Immunology. 81:1994;65-72.
177. Levenson R., Housman D. Developmental program of murine erythroleukemia cells: effect of inhibition of protein synthesis. J Cell Biol. 82:1979;715-725.
178. Levenson R., Housman D. Memory of MEL cells to a previous exposure to inducer. Cell. 17:1979;485-490.
179. Levenson R., Kernen J., Housman D. Synchronisation of MEL cell commitment with cordycepin. Cell. 18:1979;1073-1076.
180. ++ requirement for commitment. Proc Natl Acad Sci USA. 77:1980;5948-5952.
181. Levin A.A., Sturzenbecker L.J., Kazmer S., Bosakowski T., Huselton C., Allenby G., Speck J., Kratzeisen C., Rosenberger M., Lovey A., Grippo J.F. 9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXR alpha. Nature. 355:1992;359-361.
182. Li C., Rittmann L.S., Tsiftsoglou A.S., Bhargava K.K., Sartorelli A.C. Pyridine derivatives as potent inducers of erythroid differentiation in Friend leukemia cells. J Med Chem. 21:1978;874-877.
183. Li C., Mella S.L., Sartorelli A.C. Cyclic urea and thiourea derivatives as inducers of murine erythroleukemia differentiation. J Med Chem. 24:1981;1089-1092.
184. Li C., Schwartz E.L., Mella S.L., Rittmann L.S., Sartorelli A.C. Induction of differentiation of leukemia cells in vitro by N-substituted amides, lactams, and 2-pyridones. J Med Chem. 24:1981;1092-1094.
185. Liebermann D.A., Hoffman B. Myeloid differentiation (MyD) primary response genes in hematopoiesis. Oncogene. 21:2002;3391-3402.
186. Lin T.-S., Cheng J.-C., Ishiguro K., Sartorelli A. Purine and 8-substituted purine arabinofuranosyl and ribofuranosyl nucleoside derivatives as potential inducers of the differentiation of the Friend erythroleukemia. J Med Chem. 28:1985;1481-1485.
187. Lin R.J., Nagy L., Inoue S., Shao W., Miller W.H. Jr., Evans R.M. Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature. 391:1998;811-814.
188. Liu H., Lo C.R., Jones B.E., Pradhan Z., Srinivasan A., Valentino K.L., Stockert R.J., Czaja M.J. Inhibition of c-myc expression sensitizes hepatocytes to tumor necrosis factor-induced apoptosis and necrosis. J Biol Chem. 275:2000;40155-40162.
189. Loflin P.T., Altschuler E., Hochhauser D., Hickson I.D., Zwelling L.A. Phorbol ester-induced down-regulation of topoisomerase II alpha mRNA in a human erythroleukemia cell line. Evidence for a post-transcriptional mechanism. Biochem Pharmacol. 52:1996;1065-1072.
190. Lotan R., Francis G.E., Freeman C.S., Waxman S. Differentiation therapy. Cancer Res. 50:1990;3453-3464.
191. Lozzio C.B., Lozzio B.B. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood. 45:1975;321-334.
192. Lozzio C.B., Lozzio B.B., Machado E.A., Fuhr J.E., Lair S.V., Bamberger E.G. Effects of sodium butyrate on human chronic myelogenous leukaemia cell line K562. Nature. 281:1979;709-710.
193. Lucas D.L., Webster H.K., Wright D.G. Purine metabolism in myeloid precursor cells during maturation. Studies with the HL-60 cell line. J Clin Invest. 72:1983;1889-1900.
194. Lui M.S., Faderan M.A., Liepnieks J.J., Natsumeda Y., Olah E., Jayaram H.N., Weber G. Modulation of IMP dehydrogenase activity and guanylate metabolism by tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide). J Biol Chem. 259:1984;5078-5082.
195. MacFarlane D.E., Manzel L. Activation of beta-isozyme of protein kinase C (PKC-β) is necessary and sufficient for phorbol ester-induced differentiation of HL-60 promyelocytes. Studies with PKC beta-defective PET mutant. J Biol Chem. 269:1994;4327-4331.
196. Macfarlane D.E., O'Donnell P.S. Phorbol ester induces apoptosis in HL-60 promyelocytic leukemia cells but not in HL-60 PET mutant. Leukemia. 7:1993;1846-1851.
197. Maekawa T., Metcalf D., Gearing D.P. Enhanced suppression of human myeloid leukemic cell lines by combinations of IL-6, LIF, GM-CSF and G-CSF. Int J Cancer. 45:1990;353-358.
198. Malinin G.I., Ebert P.S. Induction of erythroid differentiation in murine erythroleukemic cells by short chain aliphatic carbonyl compounds and their corresponding precursors. Evidence for common inducing signal. FEBS Lett. 109:1980;264-266.
199. Mallia C.M., Aguirre V., McGary E., Tang Y., Scandurro A.B., Liu C., Noguchi C.T., Beckman B.S. Protein kinase calpha is an effector of hexamethylene bisacetamide-induced differentiation of Friend erythroleukemia cells. Exp Cell Res. 246:1999;348-354.
200. Mangelsdorf D.J., Evans R.M. The RXR heterodimers and orphan receptors. Cell. 83:1995;841-850.
201. Maroulakou I.G., Bowe D.B. Expression and function of Ets transcription factors in mammalian development: a regulatory network. Oncogene. 19:2000;6432-6442.
202. Marks P.A., Rifkind R.A. Erythroleukemic differentiation. Annu Rev Biochem. 47:1978;419-448.
203. Mason-Garcia M., Beckman B.S. Signal transduction in erythropoiesis. FASEB J. 5:1991;2958-2964.
204. Matushansky I., Radpavar F., Skoultchi A.I. Manipulating the onset of cell cycle withdrawal in differentiated erythroid cells with cyclin-dependent kinases and inhibitors. Blood. 96:2000;2755-2764.
205. 1. Proc Natl Acad Sci USA. 97:2000;14317-14322.
206. McCachren S.S. Jr., Nichols J., Kaufman R.E., Niedel J.E. Dibutyryl cyclic adenosine monophosphate reduces expression of c-myc during HL-60 differentiation. Blood. 68:1986;412-416.
207. 3 inhibits proliferation of human promyelocytic leukaemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal human bone marrow cells. Leuk Res. 7:1983;51-55.
208. McKenna S.L., Cotter T.G. Functional aspects of apoptosis in hematopoiesis and consequences of failure. Adv Cancer Res. 71:1997;121-164.
209. 2+-dependent endonuclease activity during the early stages of murine erythroleukemic cell differentiation. Proc Natl Acad Sci USA. 81:1984;7461-7465.
210. Melnick A., Licht J.D. Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood. 93:1999;3167-3215.
211. Metcalf D. Actions and interactions of G-CSF, LIF, and IL-6 on normal and leukemic murine cells. Leukemia. 3:1989;349-355.
212. Metcalf D. Lineage commitment and maturation in hematopoietic cells: the case for extrinsic regulation. Blood. 92:1998;345-348.
213. 3 induces differentiation of human myeloid leukemia cells. Biochem Biophys Res Commun. 102:1981;937-943.
214. Miyaura C., Onozaki K., Akiyama Y., Taniyama T., Hirano T., Kishimoto T., Suda T. Recombinant human interleukin 6 (B-cell stimulatory factor 2) is a potent inducer of differentiation of mouse myeloid leukemia cells (M1). FEBS Lett. 234:1988;17-21.
215. + cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science. 83:1999;682-686.
216. Momparler R.L., Dore B.T., Momparler L.F. Effect of 5-aza-2′- deoxycytidine and retinoic acid on differentiation and c-myc expression in HL-60 myeloid leukemic cells. Cancer Lett. 54:1990;21-28.
217. Mulligan R.G. The basic science of gene therapy. Science. 260:1993;926-932.
218. Murate T., Kagami Y., Hotta T., Yoshida T., Saito H., Yoshida S. Terminal differentiation of human erythroleukemia cell line K562 induced by aphidicolin. Exp Cell Res. 191:1990;45-50.
219. Nagai T., Igarashi K., Akasaka J., Furuyama K., Fujita H., Hayashi N., Yamamoto M., Sassa S. Regulation of NF-E2 activity in erythroleukemia cell differentiation. J Biol Chem. 273:1998;5358-5365.
220. Nakaya K., Chou S., Degushi Y., Nakamura Y. Induction of differentiation of human leukemia cells by various combinations of cytokines and low-molecular-weight inducers. Chem Pharm Bull. 38:1990;966-970.
221. Nakayasu M., Terada M., Tamura G., Sugimura T. Induction of differentiation of human and murine myeloid leukemia cells in culture by tunicamycin. Proc Natl Acad Sci USA. 77:1980;409-413.
222. Nasi S., Ciarapica R., Jucker R., Rosati J., Soucek L. Making decisions through Myc. FEBS Lett. 490:2001;153-162.
223. Nerlov C., Querfurth E., Kulessa H., Graf T. GATA-1 interacts with the myeloid PU.1 transcription factor and represses PU.1-dependent transcription. Blood. 95:2000;2543-2551.
224. Nervi C., Poindexter E.C., Grignani F., Pandolfi P.P., Lo Coco F., Avvisati G., Pelicci P.G., Jetten A.M. Characterization of the PML-RAR alpha chimeric product of the acute promyelocytic leukemia-specific t(15;17) translocation. Cancer Res. 52:1992;3687-3692.
225. Newmark H.L., Young C.W. Butyrate and phenylacetate as differentiating agents: practical problems and opportunities. J Cell Biochem (Suppl). 22:1995;247-253.
226. Ng H.H., Bird A. DNA methylation and chromatin modification. Curr Opin Genet Dev. 9:1999;158-163.
227. Ngai J., Capetanaki Y.G., Lazarides E. Differentiation of murine erythroleukemia cells results in the rapid repression of vimentin gene expression. J Cell Biol. 99:1984;306-314.
228. Nielsen A.L., Norby P.L., Pedersen F.S., Jorgensen P. E-box sequence and context-dependent TAL1/SCL modulation of basic helix-loop-helix protein-mediated transcriptional activation. J Biol Chem. 271:1996;31463-31469.
229. Niitsu N., Honma Y. Adenosine analogs as possible differentiation- inducing agents against acute myeloid leukemia. Leuk Lymphoma. 34:1999;261-271.
230. Nilsson G., Carlsson M., Jones I., Ahlstedt S., Matsson P., Nilsson K. TNF-alpha and IL-6 induce differentiation in the human basophilic leukaemia cell line KU812. Immunology. 81:1994;73-78.
231. Nutt S.L., Heavey B., Rolink A.G., Busslinker M. Commitment of the B-lymphoid lineage depends on the transcription factor Pax5. Nature. 401:1999;556-562.
232. Oh I.-H., Reddy E.P. The myb gene family in cell growth, differentiation and apoptosis. Oncogene. 18:1999;3017-3033.
233. Oikawa T., Yamada T. Molecular biology of the Ets family of transcription factors. Gene. 303:2003;11-34.
234. Oikawa T., Yamada T., Kihara-Negishi F., Yamamoto H., Kondoh N., Hitomi Y., Hashimoto Y. The role of Ets family transcription factor PU.1 in hematopoietic cell differentiation, proliferation and apoptosis. Cell Death Differ. 6:1999;599-608.
235. Okuma E., Inazawa Y., Saeki K., Yuo A. Potential roles of extracellular signal-regulated kinase but not p38 during myeloid differentiation of U937 cells stimulated by cytokines. Augmentation of differentiation via prolonged activation of extracellular signal-regulated kinase. Exp Hematol. 30:2002;571-581.
236. Olah E., Natsumeda Y., Ikegami T., Kote Z., Horanyi M., Szelenyi J., Paulik E., Kremmer T., Hollan S.R., Sugar J., Weber G. Induction of erythroid differentiation and modulation of gene expression by tiazofurin in K-562 leukemia cells. Proc Natl Acad Sci USA. 85:1988;6533-6537.
237. Orkin S.H. Transcription factors and hematopoietic development. J Biol Chem. 270:1995;4955-4958.
238. Orkin S.H. Diversification of hematopoietic stem cells to specific lineages. Nat Rev Genet. 1:2000;57-64.
239. Orkin S.H., Harosi F.I., Leder P. Differentiation in erythroleukemic cells and their somatic hybrids. Proc Natl Acad Sci USA. 72:1975;98-102.
240. 3: preferential activity in inducing differentiation of human leukemia cells HL-60 in vitro. Proc Natl Acad Sci USA. 84:1987;2610-2614.
241. Pakkala I., Savli H., Knuutila S., Binderup L., Pakkala S. CB1093, a novel vitamin D analog; effects on differentiation and clonal growth on HL-60 and de novo leukemia cells. Leuk Res. 21:1997;321-326.
242. Palma J.F., Gao X., Lin C.H., Wu S., Solomon W.B. Iron protoporphyrin IX (hemin) but not tin or zinc protoporphyrin IX can stimulate gene expression in K562 cells from enhancer elements containing binding sites for NF-E2. Blood. 84:1994;1288-1297.
243. Pantazis P. The water-insoluble camptothecin analogues: promising drugs for the effective treatment of haematological malignancies. Leuk Res. 19:1995;775-788.
244. Paoletti F., Vannucchi A.M., Mocali A., Caporale R., Burstein S.A. Identification and conditions for selective expression of megakaryocytic markers in Friend erythroleukemia cells. Blood. 86:1995;2624-2631.
245. Papac R.J., Brown A.E., Schwartz E.L., Sartorelli A.C. Differentiation of human promyelocytic leukemia cells in vitro by 6-thioguanine. Cancer Lett. 10:1980;33-38.
246. Pappas I.S., Niopas I., Tsiftsoglou A.S. Ureido derivatives of pyridine: a new class of inducers of murine erythroleukemia cell differentiation. Anticancer Drug Des. 7:1992;153-161.
247. Pappas I.S., Sophianos D., Tzartos S., Tsiftsoglou A.S. Expression of memory, differentiation, and repression of c-myc and p53 genes in human RD/TE-671 cells induced by a ureido-derivative of pyridine (UDP-4). Cell Growth Differ. 7:1996;797-809.
248. Pappas I.S., Vizirianakis I.S., Tsiftsoglou A.S. Cloning, sequencing and expression of a cDNA encoding the mouse L35a ribosomal protein during differentiation of murine erythroleukemia (MEL) cells. Cell Biol Int. 25:2001;629-634.
249. Pappas, I. S., Lambris, J., Vizirianakis, I. S., & Tsiftsoglou A. S. (2003). Mechanisms of action of chemical inducers: detection of an inducer-binding protein from murine erythroleukemia cells. Submitted for publication.
250. Peltz S.W., Brewer G., Bernstein P., Hart A., Ross J. Regulation of mRNA turnover in eukaryotic cells. Crit Rev Eukar Gene Expression. 1:1991;99-126.
251. Perigaud C., Gosselin G., Imbach J. Nucleoside analogs as chemotherapeutic agents: a review. Nucleosides Nucleotides. 11:1992;903-945.
252. Pierce G.B. Neoplasms, differentiations and mutations. Am J Pathol. 77:1974;103-118.
253. Poindessous-Jazat V., Augery-Bourget Y., Robert- Lézénès J. c-jun modulates apoptosis but not terminal cell differentiation in murine erythroleukemia cells. Leukemia. 16:2002;233-243.
254. Prasad-Srinivasa K.S., Jordan E.J., Koury J.M., Bondurant C.M., Brandt J.S. Erythropoietin stimulates transcription of the TAL1/SCL gene and phosphorylation of its protein products. J Biol Chem. 270:1995;11603-11611.
255. Prochownik E.V., Kukowska J. Deregulated expression of c-myc by murine erythroleukemia cells prevents differentiation. Nature. 322:1986;848-850.
256. 1 progression in murine erythroleukemia cells. Mol Cell Biol. 91:1988;3685-3686.
257. Pugh C.S.G., Borchardt R.T., Stone H.O. Inhibition of Newcastle disease virion messenger RNA (guanine-7-)-methyltransferase by analogues of S-adenosyl-homocysteine. Biochemistry. 16:1977;3928-3932.
258. Pulito V.L., Miller D.L., Sassa S., Yamane T. DNA fragments in Friend erythroleukemia cells induced by dimethylsulfoxide. Proc Natl Acad Sci USA. 80:1983;5912-5915.
259. Pulverer B.J., Hughes K., Franklin C.C., Kraft A.S., Leevers S.J., Woodgett J.R. Co-purification of mitogen-activated protein kinases with phorbol ester-induced c-Jun kinase activity in U937 leukaemic cells. Oncogene. 8:1993;407-415.
260. Rane S.G., Reddy E.P. JAKS, STATS and Src kinases in hematopoiesis. Oncogene. 21:2002;3334-3358.
261. Ramsay R.G., Ikeda K., Rifkind R.A., Marks P.A. Changes in gene expression associated with induced differentiation of erythroleukemia: protoncogenes, globin genes and cell division. Proc Natl Acad Sci USA. 83:1986;6849-6853.
262. Rao G., Rekhtman N., Cheng G., Krasikov T., Skoultchi A.I. Deregulated expression of the PU.1 transcription factor blocks murine erythroleukemia cell terminal differentiation. Oncogene. 14:1997;123-131.
263. Reiss M., Gamba-Vitalo C., Sartorelli A.C. Induction of tumor cell differentiation as a therapeutic approach: preclinical models for hematopoietic and solid neoplasms. Cancer Treat Rep. 70:1986;201-218.
264. Rekhtman N., Radparvar F., Evans T., Skoultchi A.I. Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: functional antagonism in erythroid cells. Genes Dev. 13:1999;1398-1411.
265. Renaud J.P., Rochel N., Ruff M., Vivat V., Chambon P., Gronemeyer H., Moras D. Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid. Nature. 378:1995;681-689.
266. Reuben R.C., Wife R.L., Breslow R., Rifkind R.A., Marks P.A. A new group of potent inducers of differentiation in murine erythroleukemia cells. Proc Natl Acad Sci USA. 73:1976;862-866.
267. Richon V.M., Rifkind R.A., Marks P.A. Expression and phosphorylation of the retinoblastoma protein during induced differentiation of murine erythroleukemia cells. Cell Growth Differ. 3:1992;413-420.
268. Richon V.M., Webb Y., Merger R., Sheppard T., Jursic B., Ngo L., Civoli F., Breslow R., Rifkind R.A., Marks P.A. Second generation hybrid polar compounds are potent inducers of transformed cell differentiation. Proc Natl Acad Sci USA. 93:1996;5705-5708.
269. Richon V.M., Emiliani S., Verdin E., Webb Y., Breslow R., Rifkind R.A., Marks P.A. A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases. Proc Natl Acad Sci USA. 95:1998;3003-3007.
270. Rickard K.L., Gibson P.R., Young G.P., Phillips W.A. Activation of protein kinase C augments butyrate-induced differentiation and turnover in human colonic epithelial cells in vitro. Carcinogenesis. 20:1999;977-984.
271. Rifkind R.A., Richon V.M., Marks P.A. Induced differentiation, the cell cycle, and the treatment of cancer. Pharmacol Ther. 69:1996;97-102.
272. Robertson K.D. DNA methylation and chromatin - unraveling the target web. Oncogene. 21:2002;5361-5379.
273. Robertson K.D., Wolffe A.P. DNA methylation in health and disease. Nat Rev Genet. 1:2000;11-19.
274. Rodrigue C.M., Arous N., Bachir D., Smith-Ravin J., Romeo P.-H., Galacteros F., Garel M.-C. Resveratrol, a natural dietary phytoalexin, possesses similar properties to hydroxyurea towards erythroid differentiation. Br J Haematol. 113:2001;500-507.
275. Ross D.D., Chen S.R., Cuddy D.P. Effects of 1-beta-D- arabinofuranosylcytosine on DNA replication intermediates monitored by pH-step alkaline elution. Cancer Res. 50:1990;2658-2666.
276. Roth W.W., Bragg P.W., Corrias M.V., Reddy N.S., Dholakia J.N., Wahba A.J. Expression of a gene for mouse eukaryotic elongation factor Tu during murine erythroleukemic cell differentiation. Mol Cell Biol. 7:1987;3929-3936.
277. Rovera G., Santoli D., Damsky G. Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with phorbol diesters. Proc Natl Acad Sci USA. 76:1979;2729-2734.
278. Rovera G., O'Brien T.G., Diamond L. Induction of differentiation in human promyelocytic leukemia cells by tumor promoters. Science. 204:1979;868-870.
279. Rowley J.D. Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature. 243:1973;290-293.
280. Rowley J.D. Chromosome translocations, dangerous liaisons revisited. Nat Rev Cancer. 1:2001;245-250.
281. Rowley P.T., Ohlsson-Wilhelm B.M., Farley B.A., LaBella S. Inducers of erythroid differentiation in K562 human leukemia cells. Exp Hematol. 9:1981;32-37.
282. Rutherford T.R., Clegg J.B., Weatherall D.J. K562 human leukaemic cells synthesise embryonic haemoglobin in response to haemin. Nature. 280:1979;164-165.
283. Ryan J.J., Prochownik E., Gottlieb C.A., Apel I.J., Merino R., Nuñez G., Clarke M.F. c-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle. Proc Natl Acad Sci USA. 91:1994;5878-5882.
284. Sachs L. The analysis of regulatory mechanisms in differentiation. Sela M. New Perspectives in Biology. 1964;246-260 Elsevier, Amsterdam.
285. Sachs L. Constitutive uncoupling of pathways of gene expression that control growth and differentiation in myeloid leukemia: a model for the origin and progression of malignancy. Proc Natl Acad Sci USA. 77:1980;6152-6156.
286. Saito A., Yamashita T., Mariko Y., Nosaka Y., Tsuchiya K., Ando T., Suzuki T., Tsuruo T., Nakanishi O. A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors. Proc Natl Acad Sci USA. 96:1999;4592-4597.
287. Samid D., Shack S., Sherman L.T. Phenylacetate: a novel nontoxic inducer of tumor cell differentiation. Cancer Res. 52:1992;1988-1992.
288. Samid D., Yeh A., Prasanna P. Induction of erythroid differentiation and fetal hemoglobin production in human leukemic cells treated with phenylacetate. Blood. 80:1992;1576-1581.
289. -/- mice expressing SCL under the control of a stem cell enhancer. Development. 128:2001;4815-4827.
290. Scher B.M., Scher W., Robinson A., Waxman S. DNA ligase and DNAse activities in mouse erythroleukemia cells during DMSO-induced differentiation. Cancer Res. 42:1982;1300-1306.
291. Scher W., Scher B.M., Waxman S. Nuclear events during differentiation of erythroleukemia cells. Dunn C.D.R. Current Concepts of Erythropoiesis. 1983;301-388 Wiley, New York.
292. Schuetze S., Paul R., Gliniak B.C., Kabat D. Role of the PU.1 transcription factor in controlling differentiation of Friend erythroleukemia cells. Mol Cell Biol. 12:1992;2967-2975.
293. Schuhmacher M., Kohlhuber F., Holzel M., Kaiser C., Burtscher H., Jarsch M., Bornkamm G.W., Laux G., Polack A., Weidle U.H., Eick D. The transcriptional program of a human B cell line in response to Myc. Nucleic Acids Res. 29:2001;397-406.
294. Schwartz E.L., Sartorelli A.C. Structure-activity relationships for the induction of differentiation of human HL-60 acute promyelocytic leukemia cells by anthracyclines. Cancer Res. 42:1981;2651-2655.
295. Schwartz E.L., Brown B.J., Nierenburg M., Marsh J.C., Sartorelli A.C. Evaluation of some anthracycline antibiotics in an in vivo model for studying drug-induced human leukemia cell differentiation. Cancer Res. 43:1983;2725-2730.
296. Schwartz E.L., Ishiguro K., Sartorelli A.C. Induction of leukemia cell differentiation by chemotherapeutic agents. Adv Enzyme Regul. 21:1983;3-20.
297. Semizarov D., Glesne D., Laouar A., Schiebel K., Huberman E. A lineage-specific protein kinase crucial for myeloid maturation. Proc Natl Acad Sci USA. 95:1998;15412-15417.
298. Shayo C.C., Mladovan A.G., Baldi A. Differentiating agents modulate topoisomerase I activity in U-937 promonocytic cells. Eur J Pharmacol. 324:1997;129-133.
299. Sheffery M., Rifkind R.A., Marks P.A. Murine erythroleukemia cell differentiation: DNAse I hypersensitivity and DNA methylation near the globin genes. Proc Natl Acad Sci USA. 79:1982;1180-1184.
300. 1-globin gene. J Mol Biol. 172:1984;417-436.
301. Sherman M.L., Shafman T.D., Spriggs D.R., Kufe D.W. Inhibition of murine erythroleukemia cell differentiation by 3-deazaadenosine. Cancer Res. 45:1985;5830-5834.
302. Sherman M.L., Shafman T.D., Kufe D.W. Modulation of cyclic AMP levels and differentiation by adenosine analogs in mouse erythroleukemia cells. J Cell Physiol. 134:1988;429-436.
303. Sherman M.L., Stone R.M., Datta R., Bernstein S.H., Kufe D.W. Transcriptional and post-transcriptional regulation of c-jun expression during monocytic differentiation of human myeloid leukemic cells. J Biol Chem. 265:1990;3320-3323.
304. 3 analogues: disassociation of their prominent antileukemic effects from their lack of calcium modulation. Cancer Res. 61:2001;3361-3368.
305. Shoji W., Yamamoto T., Obinata M. The helix-loop-helix protein Id inhibits differentiation of murine erythroleukemia cells. J Biol Chem. 269:1994;5078-5084.
306. Shtivelman E., Lifshitz B., Gale R.P., Canaani E. Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature. 315:1985;550-554.
307. Sintchak M.D., Fleming M.A., Futer O., Raybuck S.A., Chambers S.P., Caron P.R., Murcko M.A., Wilson K.P. Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid. Cell. 85:1996;921-930.
308. Skalnik D.G. Transcriptional mechanisms regulating myeloid-specific genes. Gene. 284:2002;1-21.
309. Smith M.J., Prochownik E.V. Inhibition of c-jun causes reversible proliferative arrest and withdrawal from the cell cycle. Blood. 79:1992;2107-2115.
310. Smithgall T.E. Signal transcription pathways regulating hematopoietic differentiation. Pharmacol Rev. 50:1998;1-19.
311. Socolovsky M., Lodish H.F., Daley G.Q. Control of hematopoietic differentiation: lack of specificity in signaling by cytokine receptors. Proc Natl Acad Sci USA. 95:1998;6573-6575.
312. Sokoloski J.A., Beardsley G.P., Sartorelli A.C. Mechanism of the induction of the differentiation of HL-60 leukemia cells by antifolates. Cancer Commun. 1:1989;199-207.
313. Sokoloski J.A., Blair O.C., Carbone R., Sartorelli A.C. Induction of the differentiation of synchronized HL-60 leukemia cells by tiazofurin. Exp Cell Res. 182:1989;234-241.
314. Spadaccini A., Tilbrook P.A., Sarna M.K., Crossley M., Bieker J.J., Klinken S.P. Transcription factor erythroid Krüppel-like factor (EKLF) is essential for the erythropoietin-induced hemoglobin production but not for proliferation, viability, or morphological maturation. J Biol Chem. 273:1998;23793-23798.
315. Sparatore B., Pessino A., Patrone M., Passalacqua M., Melloni E., Pontremoli S. Changes in calcium influx affect the differentiation of murine erythroleukaemia cells. Biochem J. 305:1995;285-290.
316. Spotts G.D., Hann S.R. Enhanced translation and increased turnover of c-myc proteins occur during differentiation of murine erythroleukemia cells. Mol Cell Biol. 10:1990;3952-3964.
317. Steinheider G., Westendorf J., Marquardt H. Induction of erythroid differentiation by the anthracycline antitumor antibiotics, aclacinomycin A, musettamycin and marcellomycin. Leuk Res. 10:1986;1233-1239.
318. Stone R.M., Sariban E., Pettit G.R., Kufe D.W. Bryostatin 1 activates protein kinase C and induces monocytic differentiation of HL-60 cells. Blood. 72:1988;208-213.
319. Streeter D.G., Witkowski J.T., Khare G.P., Sidwell R.W., Bauer R.J., Robins R.K., Simon L.N. Mechanism of action of 1-D-ribofuranosyl-1,2,4-triazole- 3-carboxamide (Virazole), a new broad-spectrum antiviral agent. Proc Natl Acad Sci USA. 70:1973;1174-1178.
320. Sutherland J.A., Turner A.R., Mannoni P., McGann L.E., Turc J.M. Differentiation of K562 leukemia cells along erythroid, macrophage, and megakaryocyte lineages. J Biol Response Mod. 5:1986;250-262.
321. Tai G., Eun-Young J., Yuji H., Masahiko K., Toshio H., Kenji K., Kenshi F., Mitsufumi M. Different effects of cyclic AMP and butyrate on eosinophilic differentiation, apoptosis and bcl-2 expression of a human eosinophilic leukemia cell line, EoL-1. Hematol Oncol. 14:1996;181-192.
322. Tan S.K., Tang S.J., Wang M.C., Hwang J., Wang F.F. Regulation of topoisomerase II expression during the VM-26 induced differentiation of IW32 murine erythroleukemia cells. Leuk Res. 20:1996;249-257.
323. Tanaka M., Levy J., Terada M., Breslow R., Rifkind R.A., Marks P.A. Induction of erythroid differentiation in murine virus infected erythroleukemia cells by highly polar compounds. Proc Natl Acad Sci USA. 72:1975;1003-1006.
324. Tarella C., Ferrero D., Gallo E., Pagliardi L.G., Ruscetti F.W. Induction of differentiation of HL-60 cells by dimethylsulfoxide: evidence for a stochastic model not linked to cell division. Cancer Res. 42:1982;445-449.
325. Tenen D.G. Disruption of differentiation in human cancer: AML shows the way. Nat Rev Cancer. 3:2003;89-101.
326. Terada M., Epner E., Nudel U., Salmon J., Fibach E., Rifkind R.A., Marks P.A. Induction of murine erythroleukemia differentiation by actinomycin D. Proc Natl Acad Sci USA. 75:1978;2795-2799.
327. Terada M., Nudel U., Fibach E., Rifkind R.A., Marks P.A. Changes in DNA associated with induction of erythroid differentiation by dimethyl-sulfoxide in murine erythroleukemia cells. Cancer Res. 38:1978;835-840.
328. Tonetti D.A., Henning-Chubb C., Yamanishi D.T., Huberman E. Protein kinase C-beta is required for macrophage differentiation of human HL-60 leukemia cells. J Biol Chem. 269:1994;23230-23235.
329. Trinchieri G., Rosen M., Perussia B. Retinoid acid cooperates with tumor necrosis factor and immune interferon in inducing differentiation and growth inhibition of the human promyelocytic leukemic cell line HL-60. Blood. 69:1987;1218-1224.
330. Tsiftsoglou A.S., Robinson S.H. Differentiation of leukemic cell lines: a review focusing on murine erythroleukemia and human HL-60 cells. Int J Cell Cloning. 3:1985;349-366.
331. Tsiftsoglou A.S., Sartorelli A.C. Dimethylsulfoxide (DMSO) induced erythroid differentiation of Friend leukemia cells in the absence of cytokinesis. Cancer Res. 39:1979;4058-4063.
332. Tsiftsoglou A.S., Sartorelli A.C. Relationship between cellular replication and erythroid differentiation of murine leukemia cells. Biochem Biophys Acta. 653:1981;226-235.
333. Tsiftsoglou A.S., Sartorelli A.C. Changes in surface architecture during murine erythroleukemia cell differentiation as detected by lectin binding and agglutination. Biochem Biophys Acta. 649:1981;105-112.
334. Tsiftsoglou A.S., Wong W. Molecular and cellular mechanisms of leukemic hemopoietic cell differentiation: an analysis of the fiend system. Anticancer Res. 5:1985;81-99.
335. Tsiftsoglou A.S., Bernett R.J., Sartorelli A.C. Enucleation of differentiated murine erythroleukemia cells in culture. Proc Natl Acad Sci USA. 76:1979;6381-6385.
336. Tsiftsoglou A.S., Mitrani A.A., Housman D.E. Procaine inhibits the erythroid differentiation of MEL cells by blocking commitment: possible
337. Tsiftsoglou A.S., Bhargava K.K., Rittman L.S., Sartorelli A.C. Distribution of the inducer of differentiation bis-acetyl-diaminopentane (BADP) in murine erythroleukemia cells. J Cell Physiol. 106:1981;419-424.
338. Tsiftsoglou A.S., Wong W., Volloch V., Gusella J., Housman D. Commitment of murine erythroleukemia (MEL) cells to terminal differentiation is associated with coordinated expression of globin and ribosomal genes. Prog Clin Biol Res. 102A:1982;69-79.
339. Tsiftsoglou A.S., Nunez M.T., Wong W., Robinson S.H. Dissociation of iron transcript and heme biosynthesis form commitment to terminal maturation of murine erythroleukemia cells. Proc Natl Acad Sci USA. 80:1983;7528-7582.
340. Tsiftsoglou A.S., Wong W., Housman D. Dexamethasone-sensitive and insensitive responses during in vitro differentiation of Friend erythroleukemia cells. Biochim Biophys Acta. 759:1983;160-169.
341. Tsiftsoglou A.S., Wong W., Hyman R., Minden M., Robinson S.H. Analysis of commitment of human leukemia HL-60 cells to terminal granulocytic maturation. Cancer Res. 45:1985;2334-2339.
342. Tsiftsoglou A.S., Hensold J., Robinson S.H., Wong W. The regulatory role of commitment in gene expression during induction of leukemic cell differentiation. Harrap K.R., Connors T.A. New Avenues in Developmental Cancer Chemotherapy. 1987;205-227 Academic Press, New York.
343. Tsiftsoglou A.S., Wong W., Robinson S.H., Hensold J. Hemin increases production of β-like globin RNA transcripts in human erythroleukemia K562 cells. Dev Genet. 10:1989;311-317.
344. Tsiftsoglou A.S., Wong W., Tsamadou A.I., Robinson S.H. Cooperative effects of hemin and anthracyclines in promoting terminal erythroid maturation in K562 human erythroleukemia cells. Exp Hematol. 19:1991;928-933.
345. Tsiftsoglou A.S., Tsamadou A.I., Robinson S.H., Wong W. Hemin is transported in human leukemia K562 cells and interacts with DNA sequences. D'Aessandro N., Rausa L., Tapiero H. Specific Approaches in Cancer Therapy: Differentiation, Immunomodulation and Angiogenesis. NATO ASI Series Life Science. 1993;108-120 Springer-Verlag, Berlin.
346. Tsiftsoglou A.S., Pappas I.S., Vizirianakis I.S. The developmental program of murine erythroleukemia cells. Oncol Res. 13:2003;339-346.
347. 3 receptors. Cell. 65:1991;1255-1266.
348. Urnov F.D., Wolffe A.P., Guschin D. Molecular mechanisms of corepressor function. Curr Top Microbiol Immunol. 254:2001;1-33.
349. Vizirianakis I.S., Tsiftsoglou A.S. Hypermethylation of RNA as part of the differentiation program of murine erythroleukemia (MEL) cells. Waxman S. Challenges of Modern Medicine: Differentiation Therapy. vol. 10:1995;263-268 Ares-Serono Symposia Publications, Rome.
350. 6-methyl)-adenosylhomocysteine. Biochem Pharmacol. 50:1995;1807-1814.
351. + RNA transcripts. Biochim Biophys Acta. 1312:1996;8-20.
352. 6-methyladenosine. Biochem Pharmacol. 44:1992;927-936.
353. Vizirianakis I.S., Pappas I.S., Gougoumas D., Tsiftsoglou A.S. Expression of ribosomal protein S5 cloned gene during differentiation and apoptosis in murine erythroleukemia (MEL) cells. Oncol Res. 11:1999;409-419.
354. Vizirianakis I.S., Pappas I.S., Tsiftsoglou A.S. Differentiation- dependent repression of c-myc, B22, COX II and COX IV genes in murine erythroleukemia (MEL) cells. Biochem Pharmacol. 63:2002;1009-1017.
355. Volloch V., Housman D. Stability of globin mRNA in terminally differentiating murine erythroleukemia cells. Cell. 23:1981;509-514.
356. Volloch V., Housman D. Terminal differentiation of murine erythroleukemia cells: physical stabilization of the end-stage cells. J Cell Biol. 93:1982;390-394.
357. Volloch V., Schweitzer B., Rits S. Messenger RNA changes during differentiation of murine erythroleukemia cells. Exp Cell Res. 173:1987;38-48.
358. Vrana J.A., Wang Z., Rao A.S., Tang L., Chen J.H., Kramer L.B., Grant S. Induction of apoptosis and differentiation by fludarabine in human leukemia cells (U937): interactions with the macrocyclic lactone bryostatin 1. Leukemia. 13:1999;1046-1055.
359. Wang J.K., Morgan J.I., Spector S. Differentiation of Friend erythroleukemia cells induced by benzodiazepines. Proc Natl Acad Sci USA. 81:1984;3770-3772.
360. 3 and tumor necrosis factor alpha. Exp Hematol. 19:1991;1025-1030.
361. Wang J., Hoshino T., Redner R.L., Kajigaya S., Liu J.M. ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex. Proc Natl Acad Sci USA. 95:1998;10860-10865.
362. Wang J., Saunthararajah Y., Redner R.L., Liu J.M. Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO leukemia cells. Cancer Res. 59:1999;2766-2769.
363. Warrell R.P. Jr., He L.Z., Richon V., Calleja E., Pandolfi P.P. Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase. J Natl Cancer Inst. 90:1998;1621-1625.
364. Watanabe T., Nomura S., Kaneno T., Yamagoe S., Kamiya T., Oishi M. Cytoplasmic factors involved in erythroid differentiation in mouse erythroleukemia (MEL) cells. Cell Differ Dev. 25:1988;105-109. (Suppl).
365. Waxman S., Scher B.M., Hellinger N., Scher W. Combination cytotoxic-differentiation therapy of mouse erythroleukemia cells with 5-fluorouracil and hexamethylene bis-acetamide. Cancer Res. 50:1990;3878-3887.
366. Waxman S., Huang Y., Scher B.M., Scher M. Enhancement of differentiation and cytotoxicity of leukemia cells by combinations of fluorinated pyrimidines and differentiation inducers: development of DNA double-strand breaks. Biomed Pharmacother. 46:1992;183-192.
367. Webb Y., Zhou X., Ngo L., Cornish V., Stahl J., Erdjument-Bromage H., Tempst P., Rifkind R.A., Marks P.A., Breslow R., Richon V.M. Photoaffinity labeling and mass spectrometry identify ribosomal protein S3 as a potential target for hybrid polar cytodifferentiation agents. J Biol Chem. 274:1999;14280-14287.
368. Whalen A.M., Galasinski S.C., Shapiro P.S., Nahreini T.S., Ahn N.G. Megakaryocytic differentiation induced by constitutive activation of mitogen-activated protein kinase kinase. Mol Cell Biol. 17:1997;1947-1958.
369. Wiernik P. Acute leukemias of Adults. DeVita V.T. Jr., Hellman S., Rosenberg S.A. Cancer Principles and Practice of Oncology. 1982;1402-1426 Lippincott, Philadelphia.
370. Witt O., Schmejkal S., Pekrun A. Tributyrin plus all-trans-retinoic acid efficiently induces fetal hemoglobin expression in human erythroleukemia cells. Am J Hematol. 64:2000;319-321.
371. Witt O., Monkemeyer S., Ronndahl G., Erdlenbruch B., Reinhardt D., Kanbach K., Pekrun A. Induction of fetal hemoglobin expression by the histone deacetylase inhibitor apicidin. Blood. 101:2003;2001-2007.
372. Wittich S., Scherf H., Xie C., Brosch G., Loidl P., Gerhauser C., Jung M. Structure-activity relationships on phenylalanine-containing inhibitors of histone deacetylase: in vitro enzyme inhibition, induction of differentiation, and inhibition of proliferation in Friend leukemic cells. J Med Chem. 45:2002;3296-3309.
373. Wong W., Robinson S.H., Tsiftsoglou A.S. Relationship of mitochondrial membrane potential to hemoglobin synthesis during Friend cell maturation. Blood. 66:1985;999-1001.
374. Wu A.M., Till J.E., Siminovitch L., McCulloch E.A. A cytological study of the capacity for differentiation of normal hemopoietic colony-forming cells. J Cell Physiol. 69:1967;177-184.
375. Yamada T., Kondoh N., Matsumoto M., Yoshida M., Maekawa A., Oikawa T. Overexpression of PU.1 induces growth and differentiation inhibition and apoptotic cell death in murine erythroleukemia cells. Blood. 89:1997;1383-1393.
376. Yamamoto T., Matsui Y., Natori S., Obinata M. Cloning of a housekeeping-type gene (MER5) preferentially expressed in murine erythroleukemia cells. Gene. 80:1989;337-343.
377. Yamamoto H., Kihara-Negishi F., Yamada T., Suzuki M., Nakano T., Oikawa T. Interaction between the hematopoietic Ets transcription factor Spi-B and the coactivator CREB-binding protein associated with negative cross-talk with c-myb. Cell Growth Differ. 13:2002;69-75.
378. Yamamoto-Yamaguchi Y., Tomida M., Hozumi M., Maurer H.R., Okabe T., Takaku F. Combined effects of differentiation-inducing factor and other cytokines on induction of differentiation of mouse myeloid leukemic cells. Jpn J Cancer Res. 80:1989;115-121.
379. Yamashita T., Eto Y., Shibai H., Ogata E. Synergistic action of activin A and hexamethylene bisacetamide in differentiation of murine erythroleukemia cells. Cancer Res. 50:1990;3182-3185.
380. Yang Y.W., Chang Y.H. Induction of erythroid differentiation by 5-fluorouracil in K562 leukemia cells. Jpn J Cancer Res. 86:1995;948-955.
381. Yoshida S., Yamada M., Masaki S. Inhibition of DNA polymerase-alpha and -beta of calf thymus by 1-beta-D-arabinofuranosylcytosine-5′-triphosphate. Biochim Biophys Acta. 477:1977;144-150.
382. Yoshida M., Nomura S., Beppu T. Effects of trichostatins on differentiation of murine erythroleukemia cells. Cancer Res. 47:1987;3688-3691.
383. Yu J., Smith R.D. Sequential alterations in globin gene chromatin structure during erythroleukemia cell differentiation. Proc Natl Acad Sci USA. 260:1985;3035-3040.
384. Yu J., Lemas V., Page T., Connor J.D., Yu A.L. Induction of erythroid differentiation in K562 cells by inhibitors of inosine monophosphate dehydrogenase. Cancer Res. 49:1989;5555-5560.
385. Yu K.H., Weng L.J., Fu S., Piantadosi S., Gore S.D. Augmentation of phenylbutyrate-induced differentiation of myeloid leukemia cells using all-trans retinoic acid. Leukemia. 13:1999;1258-1265.
386. + human myeloid leukemia cells. Cancer Res. 63:2003;2118-2126.
387. Zhang P., Behre G., Pan J., Iwama A., Wara-Aswapati N., Radomska H.S., Auron P.E., Tenen D.G., Sun Z. Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1. Proc Natl Acad Sci USA. 96:1999;8705-8710.
388. Zhang P., Zhang X., Iwama A., Yu C., Smith K.A., Mueller B.U., Narravula S., Torbett B.E., Orkin S.H., Tenen D.G. PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding. Blood. 96:2000;2641-2648.
389. 3, and sodium butyrate on differentiation in HL-60 cells. Oncol Res. 12:2000;419-427.
390. Zheng X., Ravatn R., Lin Y., Shih W.C., Rabson A., Strair R., Huberman E., Conney A., Chin K.V. Gene expression of TPA induced differentiation in HL-60 cells by DNA microarray analysis. Nucleic Acids Res. 30:2002;4489-4499.
391. 3 prolongs survival time of leukemic mice. Proc Natl Acad Sci USA. 87:1990;3929-3932.
392. 3 analog with potent ability to induce HL-60 cell differentiation without modulating calcium metabolism. Blood. 78:1991;75-82.
393. Zhou X., Richon V.M., Ngo L., Rifkind R.A., Marks P.A. Cloning of the cDNA encoding phenylalanyl tRNA synthetase regulatory alpha-subunit-like protein whose expression is down-regulated during differentiation. Gene. 233:1999;13-19.
394. Zhu L., Skoultchi A.I. Coordinating cell proliferation and differentiation. Curr Opin Genet Dev. 10:2001;91-97.
395. Zhuang Y., Soriano P., Weintraub H. The helix-loop-helix gene E2A is required for B cell formation. Cell. 79:1994;875-884.
396. Zhuo S., Fan S., Huang S., Kaufman S. Study of the role of retinoblastoma protein in terminal differentiation of murine erythroleukemia cells. Proc Natl Acad Sci USA. 92:1995;4234-4238.
397. Zucker R.M., Whittington K., Price B.J. Differentiation of HL-60 cells: cell volume and cell cycle changes. Cytometry. 3:1983;414-418.